IGHE and allergic disease: In conclusion, we have identified IgE+ plasmablasts as a novel peripheral blood biomarker of allergy that precedes recurrent clinical allergy, is rapidly responsive to changes in allergen exposure, and is easily identifiable after an acid wash approach.